key: cord-0866292-rr2qweal
authors: Guzman, Benedict Vincent; Elbel, Brian; Jay, Melanie; Messito, Mary Jo; Curado, Silvia
title: Age‐dependent association of obesity with COVID‐19 severity in paediatric patients
date: 2021-09-27
journal: Pediatr Obes
DOI: 10.1111/ijpo.12856
sha: a04e6d0f27acf5fce1165a0cd96e0e7eefcd0991
doc_id: 866292
cord_uid: rr2qweal

BACKGROUND: Limited research has addressed the obesity–COVID‐19 severity association in paediatric patients. OBJECTIVE: To determine whether obesity is an independent risk factor for COVID‐19 severity in paediatric patients and whether age modifies this association. METHODS: SARS‐CoV‐2‐positive patients at NYU Langone Health from 1 March 2020 to 3 January 2021 aged 0–21 years with available anthropometric measurements: weight, length/height and/or body mass index (BMI). Modified log‐Poisson models were utilized for the analysis. Main outcomes were 1) hospitalization and 2) critical illness (intensive care unit [ICU] admission). RESULTS: One hundred and fifteen of four hundred and ninety‐four (23.3%) patients had obesity. Obesity was an independent risk factor for critical illness (adjusted risk ratio [ARR] 2.02, 95% CI 1.17 to 3.48). This association was modified by age, with obesity related to a greater risk for critical illness in adolescents (13–21 years) [ARR 3.09, 95% CI 1.48 to 6.47], but not in children (0–12 years). Obesity was not an independent risk factor for hospitalization for any age. CONCLUSION: Obesity was an independent risk factor for critical illness in paediatric patients, and this association was modified by age, with obesity related to a greater risk for critical illness in adolescents, but not in children. These findings are crucial for patient risk stratification and care.

As cases of the coronavirus disease 2019 , caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), continue to increase across the globe, more than 136.1 million infections have been reported as of 12 April 2021. 1 Of these, more than 31.2 million are in the United States, with the vast majority of the cases being reported in adults. 2, 3 Over 3.54 million infection cases have been reported within the paediatric population since the onset of the pandemic. 4 While severe SARS-CoV-2 illness is less common in the paediatric population than that in adults, hospitalization, intensive care admission and even death have occurred in children and adolescents. [5] [6] [7] It is therefore crucial to identify risk factors that may influence the severity of COVID-19 in paediatric patients.

In addition to age, sex, hypercholesterolemia and diabetes, 8, 9 obesity has been well established as an independent risk factor for adverse COVID-19 outcomes in adults. 10, 11 However, limited research has addressed the association of obesity with COVID-19 severity in Mary Jo Messito and Silvia Curado contributed equally as co-senior authors. children and adolescents. 12 The few paediatric studies conducted thus far have several limitations, such as utilizing small sample sizes, 5, 7 and examining this association without controlling for other confounding variables, such as age and sex. 5, 7, 13 Age-related differences in infection susceptibility, 14 transmission 15 and incidence 16 have been previously noted. However, no study thus far has explored possible age-related differences in the association of obesity with COVID-19 severity in paediatric patients. Because obesity affects nearly 20% of the paediatric population in the United States, 17 a deeper understanding of the association between obesity and COVID-19 severity is crucial. Moreover, it is important to know whether the possible associated risk within the paediatric population is age-dependent, to support paediatric risk stratification of developing increased COVID-19 severity and decision-making regarding patient care.

Our work aims to address these gaps in the literature and establish whether obesity is an independent risk factor for COVID -19 severity in children and adolescents by 1) analysing a relatively large paediatric cohort, 2) conducting multivariable analyses and 3) stratifying our cohort by age to explore if age is an effect modifier of the association between obesity and COVID-19 severity.

The study site was NYU Langone Health (NYULH), a network including 260 outpatient and 6 inpatient sites located in Manhattan, Brooklyn and Long Island, New York. We identified all patients with a positive result for the SARS-CoV-2 virus polymerase chain reaction (PCR) test from the assay of sputum, nasopharyngeal swab or oropharyngeal swab specimens between 1 March 2020 and 3 January 2021.

Electronic medical records of these patients, including data from previous inpatient and outpatient encounters in the health system, were retrieved from our integrated electronic health records (EHR) system (Epic Systems, Verona, WI). The inclusion criteria for the final cohort were 1) positive SARS-CoV-2 PCR test, 2) age between 0 and 21 years, and 3) anthropometric measurements (weight, length/height and/or body mass index [BMI] ) availability in the EHR. This study was approved by the NYU Institutional Review Board.

For this study, COVID-19 illness outcomes were defined as 1) hospitalization and 2) critical illness, defined as requiring admission to an intensive care unit (ICU), due to COVID-19. Hospitalization and critical illness were defined as due to COVID-19 if the patient had 1) a positive SARS-CoV-2 PCR test and 2) COVID-19-related symptoms and/or complications described in the literature, 3, 6 such as fever, shortness of breath, cough, acute respiratory distress syndrome (ARDS), pneumonia and acute respiratory failure, as recorded in the medical history, problem list, hospital problem or diagnosis fields in the EHR.

All variables were selected based on published literature 3,6,18 and clinical knowledge. The following were extracted for each patient: 1) age at the time of COVID-19 testing, categorized as children (0-12 years old) and adolescents (13-21 years old) (13 years was used as the starting age cutoff for the adolescent group because it is the mean age when menarche, which is the most definitive sign of puberty in females, 19 occurs in the United States [i.e., 12.5 years in 2013-2017] 20 ; given the scarcity of studies regarding pubertal onset in males due to the absence of an easily identifiable marker such as menarche, 21 we also designated 13 years as the starting age cutoff for males in our study.); 2) race/ ethnicity, recorded as non-Hispanic white, non-Hispanic black, Asian, Hispanic, other race or unknown; 3) male and female sex; 4) anthropometric measures: weight, length or height and/or BMI (weight in kilograms divided by height in meters squared); 5) presence of comorbidities, defined as history of asthma, any malignancy or metastatic solid tumour, congenital malformations, deformations, and chromosomal abnormalities (International Classification of Diseases, Tenth

Revision, Clinical Modification [ICD-10-CM]: Q00-Q99), and/or diabetes, as noted in the medical history, problem list, hospital problem or diagnosis fields in the EHR; 6) initial vital signs taken in the emergency department (ED) or during hospital admission, including oxygen saturation and temperature; 7) initial laboratory results taken in the ED or during hospital admission, including C-reactive protein (CRP), creatinine, d-dimer, ferritin, lymphocyte count, procalcitonin and troponin; 8) hospitalization and ICU length of stay in days; 9) COVID-19-related symptoms, including fever, shortness of breath, cough, nausea/vomiting, diarrhoea and abdominal pain; 10) COVID-19-related complications, including ARDS, pneumonia, acute respiratory failure, myocarditis, multisystem inflammatory syndrome in children (MIS-C) and acute kidney injury; and 11) oxygen delivery device required during hospitalization and/or ICU admission, including high flow nasal cannula, bilevel positive airway pressure (BiPAP) or continuous positive airway pressure (CPAP), and/or invasive mechanical ventilation (IMV).

Obesity status was determined for each patient using the US Centers for Disease Control and Prevention (CDC) growth charts. 22 Sex-specific weight-for-length (WFL) for children <24 months (2 years) Generalized estimated equation with a log-link function and a Poisson distribution was used to quantify the association between obesity and hospitalization and critical illness due to COVID-19. Risk ratios and 95% confidence intervals (CIs) for obesity were adjusted for age (dichotomized as 0-12 group and 13-21 group), sex and presence of comorbidity; other variables listed above were excluded to prevent model saturation and multicollinearity (i.e., variables with variance inflation factor [VIF] > 2 were excluded from our models).

For the critical illness multivariable model, one hospitalized patient, whose final outcome has not yet been determined (i.e., hospital discharge, critical illness or mortality), was excluded. We set a two-tailed α of 0.05 to be statistically significant. To formally test whether the association of obesity and COVID-19 severity is modified by age, an interaction term between obesity and age (obesity*age) was included in our modified log-Poisson models. Given that homogeneity tests (e.g., regression-based test of interaction) generally have very low statistical power, which may lead to undetected cases of true heterogeneity, the significance level for the interaction term was increased to 0.10. [27] [28] [29] We also conducted five sensitivity analyses: model 1) given the limitations in the predictive value of WFA in categorizing weight status, 25 we excluded 74 patients with missing length or height measurements in the EHR; model 2) given the limitations of WFL in assessing adiposity, 30 (20. 08 years); model 4) given the limitations of using WFA, WFL and adult BMI, we excluded 231 patients whose obesity status was determined using WFA, WFL or adult BMI categories, thereby limiting the cohort to 263 patients whose obesity status was determined using sex-specific BMI-for-age; model 5) given that anthropometric measures are not routinely taken during all COVID-19 testing encounters, we excluded 97 patients whose only available anthropometric measurements in the EHR were from inpatient or outpatient encounters in the health system >30 days pre-or post-COVID-19 testing encounter; model 6) given that the US CDC and US Department of Health and the Food and Drug Administration define the starting age for adolescence as 12 years, 16, 31 we utilized 12 as the starting age cutoff for the adolescent group, thereby redefining our age groups as children (0-11 years) and adolescents (12-21 years).

All data extraction and data processing were performed with pandas modules in Python, version 3.7.3; descriptive statistics were performed using the library gtsummary, and multivariable analyses were performed using the geeglm function within the library geepack 32 in R, version 3.6.1. 

Among the full cohort, hospitalized patients were more likely to be younger (median 12.0 years vs. 15.0 years; p = 0.006) and to have comorbidities of asthma ( T A B L E 2 (Continued) When separate models were created for each age group (children aged 0-12 years and adolescents aged 13-21 years) and outcome, the interaction term was not statistically significant for hospitalization (p interaction = 0.19), but was for critical illness (p interaction = 0.08) ( (20. 08 years); model 4 excludes all 231 patients whose obesity status was determined via WFL, WFA or adult BMI categories, thereby limiting the cohort to 263 patients whose obesity status was determined using sex-specific BMI-for-age; model 5 excludes all 97 patients whose only available anthropometric measurements in the EHR were from inpatient or outpatient encounters in the health system >30 days pre-or post-COVID-19 testing encounter; model 6 utilizes 12 as the starting age cutoff for the adolescent group, thereby redefining the age groups as children (0-11 years) and adolescents (12-21 years remained not an independent risk factor for hospitalization for any age, nor for critical illness in children (Table 6 ).

In this cohort study of 494 SARS-CoV-2-positive paediatric patients, though not independently associated with hospitalization, obesity was found to be an independent risk factor for COVID-19-related critical illness, and this association was modified by age. Obesity was independently related to greater risk for critical illness in adolescents, but not in children. These findings suggest that age-related differences in COVID-19 between children and adolescents exist for the association between obesity and COVID-19 severity, in addition to SARS-CoV-2 infection susceptibility, 14 transmission 15 and incidence. 16 Existing paediatric studies have suggested that obesity is associated with increased COVID-19 severity. 5, 7, 13 Our study adds to the literature by showing that within the paediatric population, the association of obesity and COVID-19 severity is age-dependent and that obesity substantially increases the risk for COVID-19-related critical illness in adolescents, but not in children. The risk of critical illness for adolescents with obesity is similar to that found in adults. 33 The underlying mechanism of obesity-driven COVID-19 severity in older paediatric patients is likely multifactorial. First, adipose tissue expansion related to obesity induces a systemic pro-inflammatory state, as characterized by an increased expression of cytokines. 34 In our study and others, 5,18 paediatric patients who experienced critical illness-regardless of obesity status-presented with a hyperinflammatory state, as evident in elevated inflammatory biomarkers such as creatinine. The chronically elevated basal inflammatory biomarker levels in patients with obesity may also contribute to the exacerbation of COVID-19 course in these patients. 35, 36 Moreover, among other organs, angiotensin-converting enzyme 2 (ACE2)-which has high affinity for SARS-CoV-2 spike proteins-is also expressed in adipose tissue. 37 The observed age-related differences in the association of obesity and COVID-19 severity may be explained in part by hormonal changes, which occur during puberty, such as the progressive decline in adiponectin, particularly in males. 38 Adiponectin has been noted as an anti-inflammatory agent, 39 who were admitted to the ICU, as having at least one comorbidity such as 'chronic lung disease (including asthma)'. 3 Our analysis shows that asthma is associated with hospitalization and critical illness. Further studies must be performed to further ascertain this association.

Any malignancy or metastatic solid tumour appears to be related to COVID-19 severity in our full cohort, but it must be noted that this association was apparent in adolescents only and that 11/15 (73.3%) of the SARS-CoV-2-positive patients with this comorbidity in this age group had obesity and 6/15 (40.0%) were 20-21 years old. Therefore, this association in our study may be confounded by age and obesity.

Other data regarding the prognosis of SARS-CoV-2-positive children and adolescents with cancer have been limited, with few studies suggesting that paediatric patients with cancer are not more vulnerable to increased COVID-19 severity than other children. 42, 43 Although diabetes has been shown to be another comorbidity linked with COVID-19-related hospitalization and critical illness in our cohort, this result must be interpreted with caution given that the number of patients with diabetes in our cohort was limited, and all of these patients were adolescents. Paediatric patients with congenital malformations, deformations and chromosomal abnormalities in our cohort, including those with congenital heart disease, were not more likely to experience COVID-19-related hospitalization and critical illness, as was reported previously by an academic centre in New York City. 44 Younger age was associated with hospitalization, but not with critical illness in our cohort, which is aligned with results reported by the CDC COVID-NET report. 13 Similarly, several studies have reported that a majority of COVID-19 cases within the paediatric population are males, 3, 45 and in our study, male sex was identified as an independent risk factor for critical illness. Reasons for this sex predisposition for increased COVID-19 severity still need to be elucidated.

Our study is not without limitations. First, our cohort size, though larger than other COVID-19 paediatric studies, was still limited. As a result, it was necessary to collapse some variables into one category (e.g., presence of comorbidities) due to insufficient exposed patients for each individual disease (e.g., any malignancy or metastatic solid tumour, diabetes), and obesity status was dichotomized as obese and non-obese, with patients with underweight, normal weight and overweight status grouped in the non-obese category. Consequently, we might have missed important associations, and CIs may have been narrower if we had a larger cohort. Second, although we found no association between obesity and MIS-C, the true cases of MIS-C in our cohort may have been undercounted given that we only considered patients to experience MIS-C if ICD-10-CM diagnosis code M30.3 was recorded in the medical history, problem list, hospital problem or diagnosis fields in the EHR. Further studies are warranted to ascertain the association between obesity and MIS-C. Third, given that we focused on a single healthcare system in one geographic location and more than 43% of our cohort were Hispanics, it is possible that there may be differences in risk factors for different paediatric settings.

Our study shows that obesity is an independent risk factor for COVID-19-related critical illness and that this association is modified by age, with obesity related to a greater risk for critical illness in adolescents, but not in children. These findings suggest that age-related differences in COVID-19 between children and adolescents are not only limited to aspects such as SARS-CoV-2 infection susceptibility, transmission and incidence, but are also apparent in the obesity-COVID-19 severity association. A better understanding of the association between obesity and COVID-19 severity is crucial for medical practitioners in stratifying paediatric risk of developing COVID-19 severity and in decision-making regarding patient care.

No conflict of interest was declared.

Mr Guzman substantially contributed to the conception and design of the study, performed acquisition of data, analysed the data, reviewed the analysis, drafted the initial manuscript, and reviewed and revised the manuscript. Drs Elbel and Jay substantially contributed to the analysis and interpretation of data, and reviewed and revised the manuscript for important intellectual content. Dr Messito substantially contributed to the conception and design of the study, and to the analysis and interpretation of data, and reviewed and revised the manuscript for important intellectual content. Dr Curado substantially contributed to the conception and design of the study, and to the analysis and interpretation of data, drafted the initial manuscript, and reviewed and revised the manuscript. All authors approved the final version to be published and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved and approved the final manuscript as submitted and agree to be accountable for all aspects of the work.

Benedict Vincent Guzman https://orcid.org/0000-0002-2791-1491

Mary Jo Messito https://orcid.org/0000-0001-5328-0593

Johns Hopkins Center for Systems Science and Engineering Coronavirus COVID-19 global cases

Coronavirus disease 2019 case surveillance -United States

Coronavirus disease 2019 in children -United States

State-Level Data Report

Epidemiology, clinical features, and disease severity in patients with coronavirus disease 2019 (COVID-19) in a Children's Hospital in new York City

Epidemiology of COVID-19 among children in China

Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Risk factors associated with mortality among patients with COVID-19 in intensive care units in

Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in new York City: prospective cohort study

High prevalence of obesity in severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation

COVID-19 and obesity in childhood and adolescence: a clinical review

Hospitalization rates and characteristics of children aged <18 years hospitalized with laboratoryconfirmed COVID-19 -COVID-NET, 14 states

Susceptibility to SARS-CoV-2 infection among children and adolescents compared with adults

Age-related differences in nasopharyngeal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) levels in patients with mild to moderate coronavirus disease 2019 (COVID-19)

COVID-19 trends among school-aged children -United States

Childhood Obesity Facts j Overweight and Obesity j CDC

Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study

Trends and patterns in menarche in the United States

Secondary sexual characteristics in boys: data from the pediatric research in office settings network

Similarity of the CDC and WHO weight-for-length growth charts in predicting risk of obesity at age 5 years

Comparison of the prevalence of shortness, underweight, and overweight among US children aged 0 to 59 months by using the CDC 2000 and the WHO 2006 growth charts

Predictive value of weight-forage to identify overweight children**

CDC All about adult BMI. Ctr Dis Control Prev. 2020. Accessed January 3, 2021

Which of these things is not like the others? Cancer

Power for tests of interaction: effect of raising the type I error rate

p value interpretations and considerations

Infant BMI or weight-for-length and obesity risk in early childhood

Age limit of pediatrics

The R package geepack for generalized estimating equations

Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships

Obesity is a risk factor for severe COVID-19 infection

Obesity, inflammation, and the gut microbiota

Circulating mononuclear cells in the obese are in a Proinflammatory state

Obesity and COVID-19: ACE 2, the missing tile

Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels

The many secret lives of adipocytes: implications for diabetes

When two pandemics meet: why is obesity associated with increased COVID-19 mortality?

Adiponectin attenuates lipopolysaccharide-induced acute lung injury through suppression of endothelial cell activation

COVID-19 in children with Cancer in new York City

Severity of COVID-19 in children with cancer: report from the United Kingdom Paediatric coronavirus Cancer monitoring project

Impact of coronavirus disease 2019 (COVID-19) on patients with congenital heart disease across the lifespan: the experience of an academic congenital heart disease Center in new York City

SARS-CoV-2 infection in children

Age-dependent association of obesity with COVID-19 severity in paediatric patients